| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087971A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087970A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087959A1 Novel benzopyran or thiobenzopyran derivatives |
| 04/04/2001 | EP0929216A4 Method of treating post menopausal diseases, including osteoporosis |
| 04/03/2001 | US6211207 Pharmaceutical composition |
| 04/03/2001 | US6211206 Pharmaceutical composition |
| 04/03/2001 | US6211205 Pharmaceutical composition |
| 04/03/2001 | US6211152 Formulations for peptide release |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021643A2 Parathyroid hormone analogues for the treatment of osteoporosis |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021213A2 Inhibition of secretion from non-neuronal cells |
| 03/29/2001 | WO2001021194A2 Method for the therapeutic management of endometriosis and fallopian tube obstruction |
| 03/29/2001 | WO2001021191A2 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | WO2000032775A9 Pth1r and pth3r receptors |
| 03/29/2001 | CA2847143A1 Inhibition of secretion from non-neuronal cells |
| 03/29/2001 | CA2805979A1 Inhibition of secretiion from non-neuronal cells |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2384816A1 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 03/29/2001 | CA2384341A1 Parathyroid hormone analogues for the treatment of osteoporosis |
| 03/29/2001 | CA2383510A1 Method for the therapeutic management of extrauterine proliferation of endometreial tissue, chronic pelvic pain and fallopian tube obstruction |
| 03/29/2001 | CA2383470A1 Inhibition of secretion from non-neuronal cells |
| 03/28/2001 | EP1086947A1 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 03/28/2001 | EP1086692A2 Estrogen agonists and antagonists for multiple indications |
| 03/28/2001 | EP1086239A1 Formulations for electroporation |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1086077A1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 03/28/2001 | CN1063668C Medicine for curing hyperthyroidism |
| 03/27/2001 | US6207640 Treatment of partial growth hormone insensitivity syndrome |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | CA2081450C Biologically active peptides containing d-2-alkyltrypthophan |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019839A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
| 03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | WO2001019770A2 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019387A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | WO2001019361A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 03/22/2001 | WO2000055155A3 Heterocyclic compounds as adenosine deaminase inhibitors |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2384991A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | CA2384974A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2383565A1 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | CA2382683A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols |
| 03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
| 03/21/2001 | EP1083935A1 Prosthetic implant and methods of use for therapeutic gene expression |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/20/2001 | US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols |
| 03/20/2001 | US6204273 Treatment of androgenic sensitive disorders such as acne vulgaris, seborrhea, female hirsutism, male pattern baldness, and benign prostatic hyperplasia. |
| 03/20/2001 | US6203789 Treating erythrocytes with s-nitroso-cysteine, homocysteine, or cysteinylglycine to reduce blood pressure |
| 03/20/2001 | CA2158399C Novel pharmaceutical product |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018049A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018028A1 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds for inhibiting oestrone sulfatase |
| 03/15/2001 | WO2001018027A1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 03/15/2001 | WO2001018025A2 17alpha propynyl 11-aryl steroids |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001017989A2 Heteroaryloxypropanolamines as beta3-adrenergic receptor agonists |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | DE19943708A1 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method |
| 03/15/2001 | DE19942812A1 Verfahren zur Herstellung von D-(3'-Pyridyl)-alanin Process for the preparation of D- (3'-pyridyl) -alanine |
| 03/15/2001 | DE19937304A1 Verwendung von CGRP-Antagonisten und CGRP-Release-Hemmern zur Bekämpfung menopausaler Hitzewallungen Use of CGRP antagonists and CGRP release inhibitors to combat menopausal hot flashes |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/14/2001 | EP1083170A1 Method for producing D-(3'-Pyridyl)-alanine |
| 03/14/2001 | EP1082960A2 Use of CRF antagonists and related compositions for treating depression and modifying the circadian rhytm |
| 03/14/2001 | EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/14/2001 | EP1082319A1 Benzocarbazol and indenoinole derived estrogenic agents |
| 03/14/2001 | EP1082298A2 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/13/2001 | US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders |
| 03/13/2001 | US6200957 Useful for treatment of variety of sex-hormone related and other conditions in both men and women |
| 03/13/2001 | US6200798 Defective recombinant adenoviruses with inactivated IVa2 gene |
| 03/13/2001 | US6200778 Genomic sequences for protein production and delivery |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | CA2146238C Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016162A1 Method for producing cyclic peptidomimetics |